Clinical Trial Update: Study of the Safety and Tolerability of PG545 in Patients With Advanced Solid Tumours [Phase 1]

View source ↗

Summary

This is a Phase 1 study evaluating the safety and tolerability of PG545 in patients with advanced solid tumours. The trial was terminated and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• PG545 (pixatimod)

Snippet

Sponsor: Zucero Pty Ltd | Conditions: Advanced Solid Tumours | Phase 1 | Status: TERMINATED | Results posted: 2012-08-02